Hartcentrum Hasselt

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1016/s0140-6736(15)60292-6 Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
https://doi.org/10.1016/s0140-6736(05)67101-2 Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)
https://doi.org/10.1016/s0140-6736(12)61253-7 Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
https://doi.org/10.1016/j.jacc.2015.05.049 Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions
https://doi.org/10.1046/j.1365-2958.2003.03432.x Global gene expression in Escherichia coli biofilms
https://doi.org/10.1056/nejmoa1911425 A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement
https://doi.org/10.1056/nejmoa2108749 Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk
https://doi.org/10.1097/hjr.0b013e328334f42d Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey
https://doi.org/10.1038/leu.2012.246 EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations
https://doi.org/10.1056/nejmoa1507854 Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes
https://doi.org/10.1016/j.crohns.2010.04.004 Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects
https://doi.org/10.1093/eurheartj/ehy223 Standardized End Point Definitions for Coronary Intervention Trials
https://doi.org/10.1016/s0140-6736(18)31714-8 Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial
https://doi.org/10.1002/ibd.20063 Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohnʼs disease after ileo-caecal resection
https://doi.org/10.1378/chest.129.3.509 Effects of Tiotropium With and Without Formoterol on Airflow Obstruction and Resting Hyperinflation in Patients With COPD
https://doi.org/10.1016/j.jacc.2014.11.053 Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates
https://doi.org/10.1371/journal.pone.0054379 Characterization of the Vaginal Micro- and Mycobiome in Asymptomatic Reproductive-Age Estonian Women
https://doi.org/10.1093/eurheartj/ehz158 The continuous heart failure spectrum: moving beyond an ejection fraction classification
https://doi.org/10.1136/bmj.n1332 P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
https://doi.org/10.1016/s0735-1097(02)02063-6 Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study
https://doi.org/10.1093/eurheartj/ehv333 Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions
https://doi.org/10.1086/647935 Bronchoalveolar Lavage Fluid Galactomannan for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases
https://doi.org/10.1016/j.jacc.2009.11.049 5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions
https://doi.org/10.1016/s0140-6736(11)60395-4 Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial
https://doi.org/10.1001/jamaoncol.2015.1883 Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing
https://doi.org/10.1016/j.jacc.2016.05.067 Standardization of Fractional Flow Reserve Measurements
https://doi.org/10.1177/2048872619894254 Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology
https://doi.org/10.1016/j.jacc.2013.12.036 4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents
https://doi.org/10.1016/j.jacc.2019.05.016 Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI
https://doi.org/10.1016/j.jcin.2015.11.015 Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?
https://doi.org/10.1016/j.jacc.2017.02.070 Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management
https://doi.org/10.1172/jci92280 Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections
https://doi.org/10.1016/j.jacc.2019.08.1038 Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting
https://doi.org/10.1016/j.jcin.2013.09.008 Two-Year Outcomes After First- or Second-Generation Drug-Eluting or Bare-Metal Stent Implantation in All-Comer Patients Undergoing Percutaneous Coronary Intervention
https://doi.org/10.1016/j.otohns.2006.02.003 Sensory Neuropathic Cough: A Common and Treatable Cause of Chronic Cough
https://doi.org/10.1001/jamacardio.2019.3355 Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes
https://doi.org/10.1161/circulationaha.121.057859 Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial
https://doi.org/10.1093/europace/euy215 Mechanisms of sex differences in atrial fibrillation: role of hormones and differences in electrophysiology, structure, function, and remodelling
https://doi.org/10.1111/j.1600-6143.2006.01320.x Severe Diarrhea in Renal Transplant Patients: Results of the DIDACT Study
https://doi.org/10.1002/cncr.24022 Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients
https://doi.org/10.1016/j.jacc.2020.11.046 Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary Syndromes
https://doi.org/10.1016/j.ejca.2011.12.003 Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses
https://doi.org/10.1136/bmjgast-2016-000097 Cachexia in cancer: what is in the definition?
https://doi.org/10.1093/eurheartj/ehz453 Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial
https://doi.org/10.1161/jaha.114.000789 Prognostic Value of Left Ventricular Diastolic Dysfunction in a General Population
https://doi.org/10.1038/s41569-019-0314-y Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease
https://doi.org/10.1093/eurheartj/ehad152 Lifelong endurance exercise and its relation with coronary atherosclerosis
https://doi.org/10.1016/j.jacc.2022.11.041 P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions
https://doi.org/10.1093/eurheartj/ehac706 Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials
https://doi.org/10.1002/ejhf.70 Combined Aerobic/Inspiratory Muscle Training vs. Aerobic Training in Patients with Chronic Heart Failure
https://doi.org/10.4244/eijy15m11_07 Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial
https://doi.org/10.1097/inf.0b013e318214b811 Reduction in Pediatric Rotavirus-related Hospitalizations After Universal Rotavirus Vaccination in Belgium
https://doi.org/10.1097/ogx.0b013e3181e09621 Diagnosis and Management of Bacterial Vaginosis and Other Types of Abnormal Vaginal Bacterial Flora: A Review
https://doi.org/10.1093/eurheartj/ehs460 Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY)
https://doi.org/10.1016/j.rmed.2008.10.002 The efficacy of tiotropium administered via Respimat® Soft Mist™ Inhaler or HandiHaler® in COPD patients
https://doi.org/10.1016/j.jacc.2016.02.056 Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes
https://doi.org/10.1016/j.ahj.2016.10.017 Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study
https://doi.org/10.1111/j.1525-1438.2006.00223.x Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature
https://doi.org/10.1016/j.rmed.2010.02.017 Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms
https://doi.org/10.1016/j.ijcard.2016.11.059 Exercise-based cardiac rehabilitation in twelve European countries results of the European cardiac rehabilitation registry
https://doi.org/10.1002/ana.25809 SCN3A‐Related Neurodevelopmental Disorder: A Spectrum of Epilepsy and Brain Malformation
https://doi.org/10.1093/eurheartj/ehy377 Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)
https://doi.org/10.1093/eurheartj/ehv038 Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial
https://doi.org/10.1016/j.ahj.2017.10.009 Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial
https://doi.org/10.1016/s0140-6736(24)01616-7 De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials
https://doi.org/10.1001/jamacardio.2024.0133 Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
https://doi.org/10.1038/ejhg.2015.26 Redefining the MED13L syndrome
https://doi.org/10.1016/j.jcin.2011.02.018 A Patient-Level Pooled Analysis Assessing the Impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score on 1-Year Clinical Outcomes in 6,508 Patients Enrolled in Contemporary Coronary Stent Trials
https://doi.org/10.1016/j.ahj.2016.01.021 Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non–ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction
https://doi.org/10.1038/leu.2011.141 Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40
https://doi.org/10.1016/j.ahj.2016.01.015 Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial
https://doi.org/10.1161/circulationaha.121.056680 Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial
https://doi.org/10.1016/j.ahj.2018.07.006 Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation—Rationale and design of the ENVISAGE-TAVI AF trial
https://doi.org/10.1093/eurheartj/ehac284 Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis
https://doi.org/10.1093/eurheartj/ehx390 Thrombo-embolic prevention after transcatheter aortic valve implantation
https://doi.org/10.1016/j.jacc.2013.09.043 Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis
https://doi.org/10.1016/j.jcin.2019.07.014 Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention
https://doi.org/10.1093/ehjcvp/pvaa009 Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
https://doi.org/10.1093/ehjcvp/pvaa106 PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY
https://doi.org/10.3171/2011.11.peds11154 Endoscopic coagulation of choroid plexus hyperplasia
https://doi.org/10.1530/eje-21-0162 ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases
https://doi.org/10.1016/j.ahj.2018.10.009 Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study
https://doi.org/10.1093/ehjcvp/pvad032 Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
https://doi.org/10.1093/eurheartj/ehu161 Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trial
https://doi.org/10.1016/j.jchf.2022.11.004 Cardiopulmonary Exercise Testing With Simultaneous Echocardiography
https://doi.org/10.1177/2047487320926776 Optimising implementation of European guidelines on cardiovascular disease prevention in clinical practice: what is needed?
https://doi.org/10.1161/circulationaha.122.063777 Reduced Ejection Fraction in Elite Endurance Athletes: Clinical and Genetic Overlap With Dilated Cardiomyopathy
https://doi.org/10.1016/j.jacc.2018.01.033 Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes
https://doi.org/10.1016/j.jcin.2018.12.031 Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials
https://doi.org/10.1001/jamanetworkopen.2023.39793 Postoperative Staphylococcus aureus Infections in Patients With and Without Preoperative Colonization
https://doi.org/10.1016/j.jcin.2020.11.046 Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI
https://doi.org/10.1161/circinterventions.120.009177 Impact of Bleeding and Myocardial Infarction on Mortality in All-Comer Patients Undergoing Percutaneous Coronary Intervention
https://doi.org/10.1093/ehjcvp/pvad016 Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)
https://doi.org/10.1016/j.jcin.2023.02.027 Impact of Preprocedural Computed Tomography on Left Atrial Appendage Closure Success
https://doi.org/10.1093/eurheartj/ehae363 Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the ESC Working Group on Cardiovascular Surgery
https://doi.org/10.1161/circulationaha.124.069012 Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome
https://doi.org/10.1161/circulationaha.123.067599 One-Year Outcomes After Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: A Prespecified Analysis of the SWISS-APERO Randomized Clinical Trial
https://doi.org/10.1093/eurheartj/ehae927 Coronary atherosclerosis in athletes: emerging concepts and preventive strategies
https://doi.org/10.1093/ehjdh/ztae042 Standardized assessment of evidence supporting the adoption of mobile health solutions: A Clinical Consensus Statement of the ESC Regulatory Affairs Committee
https://doi.org/10.1136/bmjsem-2023-001541 Effects of training adaption in endurance athletes with atrial fibrillation: protocol for a multicentre randomised controlled trial